The regulatory role of LncRNA HCG18 in various cancers.
Du Z, Wang B, Tan F, Wu Y, Chen J, Zhao F, Liu M, Zhou G, Yuan C.
Du Z, et al.
J Mol Med (Berl). 2023 Apr;101(4):351-360. doi: 10.1007/s00109-023-02297-5. Epub 2023 Mar 6.
J Mol Med (Berl). 2023.
PMID: 36872315
Review.
As outlined in this review, LncRNA HCG18 has been reported to be dysregulated in various cancers development and appears to be activated in a variety of tumors, including clear cell renal cell carcinoma (ccRCC), colorectal cancer (CRC), gastric cancer (GC), h …
As outlined in this review, LncRNA HCG18 has been reported to be dysregulated in various cancers development and appears to be activated in …